nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study
|
Connelly, Kathryn |
|
|
4 |
12 |
p. e831-e841 |
artikel |
2 |
Can lupus low disease activity state predict mortality in patients with SLE?
|
Wallace, Daniel J |
|
|
4 |
12 |
p. e806-e807 |
artikel |
3 |
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study
|
Murarasu, Anne |
|
|
4 |
12 |
p. e842-e852 |
artikel |
4 |
Checking the vitals of rheumatology care in the UK
|
The Lancet Rheumatology, |
|
|
4 |
12 |
p. e805 |
artikel |
5 |
COP27 Climate Change Conference: urgent action needed for Africa and the world
|
Atwoli, Lukoye |
|
|
4 |
12 |
p. e814-e816 |
artikel |
6 |
Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY
|
Russell, Mark D |
|
|
4 |
12 |
p. e853-e863 |
artikel |
7 |
Long COVID: defining the role of rheumatology in care and research
|
Calabrese, Leonard H |
|
|
4 |
12 |
p. e812-e814 |
artikel |
8 |
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study
|
Kandane-Rathnayake, Rangi |
|
|
4 |
12 |
p. e822-e830 |
artikel |
9 |
Maternal thrombotic and haemorrhagic complications in pregnant women with antiphospholipid syndrome
|
Schreiber, Karen |
|
|
4 |
12 |
p. e808-e810 |
artikel |
10 |
Pan American League of Associations for Rheumatology guidelines for the treatment of giant cell arteritis
|
Scolnik, Marina |
|
|
4 |
12 |
p. e864-e872 |
artikel |
11 |
Research in Brief
|
Thorley, Jennifer |
|
|
4 |
12 |
p. e819 |
artikel |
12 |
Rosa Maria Rodrigues Pereira
|
Jorgetti, Vanda |
|
|
4 |
12 |
p. e821 |
artikel |
13 |
The impact of COVID-19 on care of early inflammatory arthritis in the UK
|
MacPhie, Elizabeth |
|
|
4 |
12 |
p. e810-e812 |
artikel |
14 |
Time to reassess inclusion of laboratory items in SLE trial endpoints?
|
Sjöwall, Christopher |
|
|
4 |
12 |
p. e807-e808 |
artikel |
15 |
Uyi Ima-Edomwonyi: building rheumatology capacity in Nigeria
|
Burki, Talha |
|
|
4 |
12 |
p. e820 |
artikel |
16 |
Withholding methotrexate after COVID-19 vaccination: different strategies, same results?
|
De Medeiros-Ribeiro, Ana C |
|
|
4 |
12 |
p. e817 |
artikel |
17 |
Withholding methotrexate after COVID-19 vaccination: different strategies, same results? – Author's reply
|
Mehta, Pankti |
|
|
4 |
12 |
p. e817-e818 |
artikel |